We are live on
!
Find out more
Organogenesis Holdings
ORGO
ORGO
Fund managers haven’t disclosed any holdings of ORGO yet.
ORGO Hedge Fund Activity: Q1 2026 in Review
121 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2026, worth a combined $147M — down 59% from $360M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of ORGO and 16 opened new positions — a net loss of 23 holders — while 48 trimmed existing stakes and 35 added.
The largest buyer was Sphera Funds Management, opening a new position worth an estimated $1.91M. The largest seller was Assenagon Asset Management, cutting an estimated $12.4M.
- 121 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2026, down from 147 in Q4 2025.
- Funds reported $147M of Organogenesis Holdings stock for Q1 2026, down 59% quarter-over-quarter.
- 16 funds opened new Organogenesis Holdings positions in Q1 2026 and 39 closed out, a net change of -23 holders.
- The largest Organogenesis Holdings buyer in Q1 2026 was Sphera Funds Management, an estimated $1.91M added.
- The largest Organogenesis Holdings seller in Q1 2026 was Assenagon Asset Management, an estimated $12.4M sold.
Based on aggregated 13F filings for Q1 2026.